Invention Grant
- Patent Title: Glucagon receptor agonists
-
Application No.: US15293316Application Date: 2016-10-14
-
Publication No.: US09884093B2Publication Date: 2018-02-06
- Inventor: Jorge Alsina-Fernandez , Tamer Coskun
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Matthew T. Lord
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/605 ; A61K45/06 ; C07K14/00
Abstract:
The present invention relates to compounds with an extended duration of action at the glucagon receptor as compared to native glucagon. Specifically provided are glucagon receptor agonists with modifications to the structure of native glucagon introduced to selectively agonize the glucagon receptor over an extended period of time.
Public/Granted literature
- US20170114115A1 GLUCAGON RECEPTOR AGONISTS Public/Granted day:2017-04-27
Information query
IPC分类:
